 Samir Osman Alsheikh has a preliminary hearing set for Friday in Los Angeles. Michelle Kellerman, NPR News, the State Department. Earlier this year, drugmaker GSK stopped making Flovent, a popular inhaler for asthma patients. That left people, especially children, scrambling to find alternatives. From member station WHYY in Philadelphia, here's Alan Yu.